Although PIK3CA acts independently of TP53 inactivation to support CIN tolerance, it generally precedes the genome doubling event (Carter et al., 2012; Zack et al., 2013; Berenjeno et al., 2017). This evidence concerns the gene TP53 and cervical squamous intraepithelial neoplasia.